Latest edition: 01 Mar 2024
Share newsletter

Get the full version straight to your inbox.
Exclusive access to our best-in-class data & intelligence
Subscribe now


HHS advocates for health equity through sickle cell initiative

The US HHS Secretary called for state collaboration on a project to improve gene therapy access for sickle cell disease.

Latest news

Obesity cost US businesses $425.5bn in 2023

An Eli Lilly-sponsored GlobalData report finds that obese workers had $6,472 higher annual in medical and economic costs.

UK MHRA approves new formulation of Amgen's XGEVA

The new prefilled syringe formulation of XGEVA is intended for patients with bone metastases.

Shifting the paradigm - novel approaches to amyotrophic lateral sclerosis therapy

The ALS pipeline comprises 109 candidates in various stages of development (Phase I–III) across the 8MM.

The health risks of ultra-processed foods (UPFs) are worse than we think

Research has linked UPFs to various physical and mental health conditions.

Bristol Myers Squibb reports data from Phase III multiple sclerosis trial

According to the findings, Zeposia treatment resulted in a notably low annualised relapse rate of 0.098.

Innovent Biologics doses first subject in Phase I asthma treatment trial

The trial is designed to assess the tolerability, safety, pharmacokinetics and pharmacodynamics of IBI3002.

Artiva prepares to kick off Phase I/II trial for NK cell therapy

Artiva has also investigated AlloNK in patients with relapsed/refractory B-cell non-Hodgkin lymphoma.

Tackle future disruption with thematic intelligence 

Navigate the key forces shaping your industry – from AI to ESG, we have all the insights you need to guide your decision making.    

Get a quote
Still looking?

Search companies, themes, reports, as well as actionable data & insights spanning 22 global industries


Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward